Please view Mass General's updated visitor policy.
Across the nation, people are gearing up for summer and looking forward to enjoying beaches, swimming, boating and golf in the warm sunshine. But what if you could never go outside and enjoy the sun? For some individuals with the rare disease known as erythropoietic protoporphyria (EPP), this is a reality.
Traditionally, those who are diagnosed with EPP have had limited care and treatment options, however, Mass General has now opened the Mass General Cancer Center Porphyria Center, the first of its kind in New England.
EPP is one type of porphyria, a group of genetic disorders affecting the biosynthesis of heme – a molecule critical to the formation of hemoglobin and red blood cells. Patients with certain types of porphyria can have life-threatening and debilitating symptoms, including extreme sun sensitivity, intractable abdominal pain, seizures, kidney and liver failure.
“We are thrilled to see patients’ enthusiasm for our clinic,” says Rebecca Karp Leaf, MD, who serves as the center’s co-director, along with Amy Dickey, MD, MSc and Sarina Elmariah, MD, PhD. “Prior to our opening, many people had been traveling out of state and some internationally for treatment. Our patients have such incredible positive energy—it is a pleasure to care for them.”
While all of the clinic’s clinicians are thrilled about the new center, perhaps no one is more excited than Dickey—who herself has had the disease for many years.
“Because I have erythropoietic protoporphyria, other patients with porphyria feel like my family,” she says. “There’s a shared experience that’s difficult to put into words. When facing the medical system, I know firsthand the struggle that porphyria patients face, including misunderstanding, dismissals, incorrect preconceived notions and fractured care. I’m overjoyed to now be able to offer porphyria patients both comprehensive porphyria care and effective therapies. It’s been a long time coming.”
- Press Release
- Jan | 12 | 2022
Patients with side effects from immune checkpoint inhibitors tend to live longer.
- Patient Story
- Jan | 11 | 2022
On January 1, 2020, Carol and her husband traveled to Florida for the start of their four-month winter vacation. Carol felt fatigued as soon as she arrived, but did not initially give much thought to it. After a few days, Carol’s exhaustion had grown, and she’d developed a new pain in her abdomen.
- Jan | 5 | 2022
View frequently asked questions and guidance about the COVID-19 vaccine for Cancer Center patients.
- Press Release
- Jan | 3 | 2022
A huge unmet need exists for therapeutic targets to prevent or delay metastasis of breast cancer to the brain, the leading cause of death from the malignancy.
- Dec | 9 | 2021
Specialists from the Mass General Cancer Center will present on leading research and innovative treatment approaches at the 2021 American Society of Hematology (ASH) Annual Meeting.